Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinhua Kin-Kong Chemical and Pharmaceutical is a specialized pharmaceutical manufacturer based in Jinhua, China, primarily focused on the production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. The company is a significant producer of oral hypoglycemic agents, including Metformin Hydrochloride and various sulfonylureas like Gliclazide and Glipizide. Operating with Good Manufacturing Practice (GMP) certification, the firm supplies high-quality chemical components to pharmaceutical formulators globally. Their business model emphasizes large-scale chemical synthesis and the supply of essential medicines for metabolic and cardiovascular health. The company has established a strong reputation for reliability in the international API export market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinhua Kin-Kong Chemical and Pharmaceutical.